Neola Medical EN
  • Lung Monitoring
  • The Technology
  • Our Studies
  • About Us
  • Career
  • Investors
    • To invest in Neola Medical
    • Risks and uncertainties
    • Stock information
    • Annual General Meeting (Swedish)
    • Corporate governance
    • Certified Adviser
    • Rights Issues (Swedish)
      • Riktad Emission 2023
      • Företrädesemission 2022
      • IPO 2020
        • Teckningsoptioner av serie TO1
    • Investor Relations
    • Investor letters
    • Presentations
    • Press Releases
    • Reports and Financial Calendar
  • News
    • Press Releases
    • Articles and posts
      • 2018 – 2024
      • 2025
Select Page
BioStock in a new interview with CEO Hanna Sjöström about the latest from J.P. Morgan Conference 2024

BioStock in a new interview with CEO Hanna Sjöström about the latest from J.P. Morgan Conference 2024

Jan 17, 2024

The 42nd edition of the JPMorgan Health Conference took place last week, and one of the participants was Neola Medical. The Swedish medtech is currently preparing its lung monitoring system for a clinical study in the US. BioStock spoke to the company’s CEO Hanna...
Neola Medical has been accepted into a new scale-up program for accelerated growth

Neola Medical has been accepted into a new scale-up program for accelerated growth

Jan 16, 2024

Neola Medical is one of seven companies selected to participate in the new 10XHealth scale-up program developed by SmiLe in close collaboration with Medicon Village and partially funded by the European Regional Development Fund. The new 10XHealth program is designed...
CEO Hanna Sjöström is the first one to guest BioStock’s new video podcast, Health & Wealth!

CEO Hanna Sjöström is the first one to guest BioStock’s new video podcast, Health & Wealth!

Dec 21, 2023

Hanna Sjöström became Coca Cola’s youngest Sweden CEO ever and slept under the desk at L’Oréal. Now, she is passionate about saving preterm born infants with new lung monitoring technology. In the premiere episode, BioStock has taken the pulse of Hanna...
CEO Hanna Sjöström comments the new European patent for Neola Medicals disposables in new article by BioStock

CEO Hanna Sjöström comments the new European patent for Neola Medicals disposables in new article by BioStock

Dec 20, 2023

Neola Medical has received a new patent approval in Europe for the Neola lung monitoring system. The patent specifically covers the probes that are attached to the chest and that enable continuous monitoring of the lungs. BioStock reached out to CEO Hanna Sjöström to...
CEO Hanna Sjöström comments Neola Medicals directed share issue 2023 in new article by BioStock

CEO Hanna Sjöström comments Neola Medicals directed share issue 2023 in new article by BioStock

Dec 19, 2023

Neola Medical is in the process of establishing itself properly in the US to gear up its work with the Neola® lung monitoring system. The company is now carrying out a directed share issue of 20 million SEK to finance the development and market preparations. BioStock...
CEO Hanna Sjöström comments Q3 report 2023 in new article by BioStock

CEO Hanna Sjöström comments Q3 report 2023 in new article by BioStock

Nov 14, 2023

Lund-based Neola Medical released its report for the third quarter last week. The company’s efforts to establish itself on the US market have begun to bear fruit and they have also presented promising clinical data that further strengthens their lung monitoring system...
« Older Entries
Next Entries »
About Neola Medical

Neola Medical AB (publ) aims to advance neonatal intensive care with Neola®, a medical device designed to enable continuous lung monitoring and real-time alerts of potentially life-threatening complications. The technology is based on a cutting-edge spectroscopic method that measures changes in lung volume and oxygen gas concentration. Neola® has the potential to support better care, shorten time spent in intensive care, and contribute to healthier lives for preterm born babies. Founded in 2016 and headquartered in Lund, Sweden, Neola Medical builds on Sweden’s legacy of medical technology innovation and contributions to global health care.

Sweden, HQ

Neola Medical AB
Ideon Gateway
Scheelevägen 27
223 63 Lund
info@neolamedical.com

U.S. Office

Neola Medical, Inc.
Nordic Innovation House
470 Ramona Street PMB
Palo Alto CA 94301-1707
info@neolamedical.com

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPersonal Data Policy